IPP Bureau
AstraZeneca India appoints Dr. Sanjeev Panchal as Country President & MD
By IPP Bureau - December 14, 2022
Sanjeev is currently the Country President for AstraZeneca Malaysia
JB Pharma to buy Glenmark's ‘Razel’ for Rs. 314 crore in India and Nepal
By IPP Bureau - December 14, 2022
The acquisition marks JB Pharma’s entry into the ‘Statin’ segment which is the largest group in the cardiac therapy
BSV receives exclusive marketing and distribution right for NexoBrid in India
By IPP Bureau - December 14, 2022
To focus on providing safer burn treatments for women and armed forces
Peter Bains appointed Additional Director of Biocon
By IPP Bureau - December 13, 2022
He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels
Evonik invests in US based biopharma company ‘Allay Therapeutics’
By IPP Bureau - December 13, 2022
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
US Federal Court dismisses cancer linkage associated with Zantac
By IPP Bureau - December 13, 2022
The current ruling will assure the safety of the use of Ranitidine for Indian patients
European Commission approves SPEVIGO for generalized pustular psoriasis flares
By IPP Bureau - December 13, 2022
EC grants conditional marketing authorization based on the EFFISAYIL trial
Moderna and Merck announce personalized mRNA cancer vaccine
By IPP Bureau - December 13, 2022
Results are the first demonstration of efficacy for an investigational mRNA cancer treatment in a randomized clinical trial
Inclusion of Yoga in the treatment of breast cancer patients is highly beneficial
By IPP Bureau - December 13, 2022
The yoga protocol included gentle and restorative yoga postures(asana) with regular periods of relaxation and pranayama
Surendran Chemmenkotil to join as CEO of Metropolis Healthcare
By IPP Bureau - December 12, 2022
He is a seasoned leader with 34 years of rich and diverse experience across geographies and consumer facing companies such as Xerox India and Bharti Airtel
Alembic receives USFDA final Approval for Desonide Cream
By IPP Bureau - December 12, 2022
Desonide Cream, 0.05%, has an estimated market size of US $12 million for twelve months ending Sep 2022 according to IQVIA
Lupin launches generic version of Pennsaid in the US
By IPP Bureau - December 12, 2022
Diclofenac Sodium Topical Solution, 2% w/w (RLD PENNSAID) had estimated annual sales of US $509 million in the US (IQVIA MAT October 2022)
Alembic receives EIR for oncology injectable formulation facility at Panelav
By IPP Bureau - December 12, 2022
This was a pre-approval inspection to cover our Oncology Injectable drug products for which ANDAs were filed with USFDA
Zydus receives USFDA approval to market Silodosin and Pregabalin capsules
By IPP Bureau - December 12, 2022
Silodosin capsules treat signs and symptoms of an enlarged prostate gland
PM addresses valedictory function of 9th World Ayurveda Congress
By IPP Bureau - December 12, 2022
Expressed happiness that more than 30 countries of the world have given recognition to Ayurveda as a traditional system of medicine
